Cardio Diagnostics Holdings Depreciation & Amortization Growth & History (CDIO)
Cardio Diagnostics Holdings's depreciation and amortization was $65,233 for fiscal 2025.
View full Cardio Diagnostics Holdings company overviewCardio Diagnostics Holdings annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $65,233 | $45,495 | +230.49% |
| 2024 | 2024-12-31 | $19,738 | $556 | +2.90% |
| 2023 | 2023-12-31 | $19,182 | $3,182 | +19.89% |
| 2022 | 2022-12-31 | $16,000 | $0 | 0.00% |
| 2021 | 2021-12-31 | $16,000 | — | — |
Cardio Diagnostics Holdings quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5,593 | −$2,892 | −34.08% |
| Q1 2026 | 2026-03-31 | $5,532 | −$39,906 | −87.83% |
| Q4 2025 | 2025-12-31 | $94,077 | — | — |
| Q3 2025 | 2025-09-30 | $40,402 | $35,600 | +741.36% |
| Q2 2025 | 2025-06-30 | $8,485 | $3,691 | +76.99% |
| Q1 2025 | 2025-03-31 | $45,438 | $40,645 | +848.01% |
| Q3 2024 | 2024-09-30 | $4,802 | $0 | 0.00% |
| Q2 2024 | 2024-06-30 | $4,794 | $1 | +0.02% |
| Q1 2024 | 2024-03-31 | $4,793 | $8 | +0.17% |
| Q3 2023 | 2023-09-30 | $4,802 | $802 | +20.05% |
| Q2 2023 | 2023-06-30 | $4,793 | $793 | +19.82% |
| Q1 2023 | 2023-03-31 | $4,785 | $785 | +19.63% |
| Q3 2022 | 2022-09-30 | $4,000 | — | — |
| Q2 2022 | 2022-06-30 | $4,000 | — | — |
| Q1 2022 | 2022-03-31 | $4,000 | — | — |
Cardio Diagnostics Holdings depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, Cardio Diagnostics Holdings's depreciation and amortization increased from $16,000 to $65,233, a change of $49,233. The latest reported quarter, Q2 2026, shows $5,593.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cardio Diagnostics Holdings source filings ↗